CombiGene announces a public offer to the holders of shares and warrants of series TO1 in Panion Animal Health
CombiGene discloses the information provided herein pursuant to the Takeover Rules and the EU:s Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on 18 April 2019 at 08.30 a.m. CET.
Jan Nilsson (CEO)
Arne Ferstad (Chairman of the board)